Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Landmark Analysis of Imatinib Treatment in CML Chronic Phase: ES-FISH <10% Ph+ At 3 Months Associated with Better Cytogenetic Response and Improved Long-Term Event-Free Survival

Anne-Charlotte Ohm, M.D., Gisela Barbany, MD, PhD, Ingrid Arvidsson, Lab., tech., Robert Hast, M.D., Ph.D., Leif Stenke, MD, PhD

Blood (2011) 118 (21): 1702.

https://doi.org/10.1182/blood.V118.21.1702.1702

Published: 2011

Journal Articles

Landmark Analyses of BCR-ABL Using ES-FISH Early After Start of Imatinib Treatment to Newly Diagnosed CMLcp Patients Predicts Longterm Clinical Outcome.

Lotta Ohm, MD, Robert Hast, MD, PhD, Ingrid Arvidsson, Gisela Barbany, Leif Stenke, MD, PhD

Blood (2009) 114 (22): 4269.

https://doi.org/10.1182/blood.V114.22.4269.4269

Published: 2009

Journal Articles

The molecular signature of MDS stem cells supports a stem-cell origin of 5q− myelodysplastic syndromes

Lars Nilsson, Patrik Edén, Eleonor Olsson, Robert Månsson, Ingbritt Åstrand-Grundström, Bodil Strömbeck, Kim Theilgaard-Mönch, Kristina Anderson, Robert Hast, Eva Hellström-Lindberg, Jan Samuelsson, Gösta Bergh, Claus Nerlov, Bertil Johansson, Mikael Sigvardsson, Åke Borg, Sten Eirik W. Jacobsen

Blood (2007) 110 (8): 3005–3014.

https://doi.org/10.1182/blood-2007-03-079368

Published: 2007

Includes: Supplemental data

Journal Articles

A Distinct Molecular Signature of Purified Cancer Stem Cells: Evidence for a Hematopoietic Stem Cell Origin of the 5q- Syndrome.

Lars Nilsson, MD, PhD, Patrik Edén, PhD, Eleonor Olsson, Robert Månsson, Ingbritt Åstrand-Grundström, Bodil Strömbeck, Ramin Tehranchi, MD, PhD, Kim Theilgaard-Mönch, Robert Hast, MD, PhD, Eva Hellström-Lindberg, MD, PhD, Jan Samuelsson, MD, PhD, Gösta Bergh, MD, PhD, Bertil Johansson, MD, PhD, Mikael Sigvardsson, PhD, Åke Borg, PhD, Sten-Eirik W. Jacobsen, MD, PhD

Blood (2005) 106 (11): 4382.

https://doi.org/10.1182/blood.V106.11.4382.4382

Published: 2005

Journal Articles

Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes

Ramin Tehranchi, Rosangela Invernizzi, Alf Grandien, Boris Zhivotovsky, Bengt Fadeel, Ann-Mari Forsblom, Erica Travaglino, Jan Samuelsson, Robert Hast, Lars Nilsson, Mario Cazzola, Rolf Wibom, Eva Hellström-Lindberg

Blood (2005) 106 (1): 247–253.

https://doi.org/10.1182/blood-2004-12-4649

Published: 2005

Journal Articles

Erythropoiesis Is Highly Stimulated in CD34 + Cells in Low-Risk Myelodysplastic Syndromes (MDS) with an Improper Mitochondrial Function.

Ramin Tehranchi, MD, Rosangela Invernizzi, MD, PhD, Boris Zhivotovsky, PhD, Bengt Fadeel, MD, PhD, Ann-Mari Forsblom, Erica Travaglino, Jan Samuelsson, MD, Robert Hast, MD, PhD, Lars Nilsson, MD, PhD, Rolf Wibom, PhD, Alf Grandien, PhD, Mario Cazzola, MD, PhD, Eva Hellstrom-Lindberg, MD, PhD

Blood (2004) 104 (11): 473.

https://doi.org/10.1182/blood.V104.11.473.473

Published: 2004

Journal Articles

Involvement and functional impairment of the CD34 + CD38 − Thy-1 + hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8

Lars Nilsson, Ingbritt Åstrand-Grundström, Kristina Anderson, Ingrid Arvidsson, Peter Hokland, David Bryder, Lars Kjeldsen, Bertil Johansson, Eva Hellström-Lindberg, Robert Hast, Sten Eirik W. Jacobsen

Blood (2002) 100 (1): 259–267.

https://doi.org/10.1182/blood-2001-12-0188

Published: 2002

Journal Articles

Isolation and characterization of hematopoietic progenitor/stem cells in 5q-deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level

Lars Nilsson, Ingbritt Åstrand-Grundström, Ingrid Arvidsson, Björn Jacobsson, Eva Hellström-Lindberg, Robert Hast, Sten E. W. Jacobsen

Blood (2000) 96 (6): 2012–2021.

https://doi.org/10.1182/blood.V96.6.2012

Published: 2000

NARROW

Landmark Analysis of Imatinib Treatment in CML Chronic Phase: ES-FISH <10% Ph+ At 3 Months Associated with Better Cytogenetic Response and Improved Long-Term Event-Free Survival

Landmark Analyses of BCR-ABL Using ES-FISH Early After Start of Imatinib Treatment to Newly Diagnosed CMLcp Patients Predicts Longterm Clinical Outcome.

The molecular signature of MDS stem cells supports a stem-cell origin of 5q− myelodysplastic syndromes

A Distinct Molecular Signature of Purified Cancer Stem Cells: Evidence for a Hematopoietic Stem Cell Origin of the 5q- Syndrome.

Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes

Erythropoiesis Is Highly Stimulated in CD34 + Cells in Low-Risk Myelodysplastic Syndromes (MDS) with an Improper Mitochondrial Function.

Involvement and functional impairment of the CD34 + CD38 − Thy-1 + hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8

Isolation and characterization of hematopoietic progenitor/stem cells in 5q-deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only